JP3513873B2 - External preparation for skin - Google Patents
External preparation for skinInfo
- Publication number
- JP3513873B2 JP3513873B2 JP01653699A JP1653699A JP3513873B2 JP 3513873 B2 JP3513873 B2 JP 3513873B2 JP 01653699 A JP01653699 A JP 01653699A JP 1653699 A JP1653699 A JP 1653699A JP 3513873 B2 JP3513873 B2 JP 3513873B2
- Authority
- JP
- Japan
- Prior art keywords
- extract
- skin
- acerola
- external preparation
- effect
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
Description
【0001】[0001]
【発明の属する技術分野】本発明は、アセロラ抽出物と
特定の薬効成分とを配合した皮膚外用剤に関し、更に詳
細には、優れた皮膚老化防止や肌荒れ改善効果を有し、
肌にはりやつやを与えることができる皮膚外用剤に関す
る。BACKGROUND OF THE INVENTION The present invention relates to a skin external preparation containing a combination of a specific medicinal ingredients and acerola extract, more particularly, has excellent anti-skin aging and skin roughness improvement effect,
The present invention relates to a skin external preparation that can give skin a luster and gloss.
【0002】[0002]
【従来の技術】従来より、乳液、クリーム、化粧水、パ
ック、分散液、洗浄料、軟膏剤、クリーム剤、外用液剤
等の皮膚外用剤には、これらに所定の薬効を付与するこ
とを目的として細胞賦活剤や保湿剤などの薬効成分が加
えられている。例えば、肌荒れ改善、皮膚老化防止、細
胞賦活の他、切創やひげそり後の傷の治療、ひび、あか
ぎれ、ただれ、痔疾、火傷等の改善等の創傷治療を目的
に、人参抽出物、シコン抽出物、胎盤抽出物、牛血液除
蛋白質、発酵代謝産物等の薬効成分が配合されている。2. Description of the Related Art Conventionally, an external skin preparation such as an emulsion, a cream, a lotion, a pack, a dispersion, a detergent, an ointment, a cream or a liquid for external use has an object to impart a predetermined medicinal effect to them. As such, a medicinal component such as a cell activator or a moisturizer is added. For example, ginseng extract, Sikon extract for the purpose of improving rough skin, preventing skin aging, activating cells, treating wounds after cuts and shaving, and treating wounds such as cracks, cracks, sores, hemorrhoids, burns, etc. , A placenta extract, bovine blood deproteinization, a fermentative metabolite, and other medicinal components.
【0003】[0003]
【発明が解決しようとする課題】しかしながら、細胞賦
活剤を配合した皮膚外用剤では、細胞賦活剤の効果が十
分でなかったり、あるいはその薬効を得るのに十分な量
を配合すると安定性に欠けたり使用感が損なわれるなど
の問題点があった。本発明はかかる問題点を解消した皮
膚外用剤を提供することを目的とする。[SUMMARY OF THE INVENTION However, in the external skin preparation containing a combination of cell activator, or not enough, the effect of cell-activating agent, or it is blended an amount sufficient to obtain the efficacy less stable However, there was a problem that the usability was lost. An object of the present invention is to provide an external preparation for skin that solves such problems.
【0004】[0004]
【課題を解決するための手段】本発明者らは、細胞賦活
剤の薬効成分の効果を向上させるべく鋭意検討を行った
結果、アセロラ抽出物と細胞賦活剤とを組み合わせるこ
とによって、細胞賦活剤の本来の有する薬効成分の作用
が十分発揮されることを見出し、本発明を完成した。す
なわち、本発明は、(A)アセロラ抽出物、並びに
(B)細胞賦活剤たる胎盤抽出物を含有する皮膚外用剤
である。[Means for Solving the Problems] The present inventors
As a result of intensive studies to improve the effect of the medicinal component of the agent, by combining the acerola extract and the cell activating agent, it was found that the action of the intrinsic medicinal ingredient of the cell activating agent is sufficiently exerted, The present invention has been completed. That is, the present invention is a skin external preparation containing (A) an acerola extract and (B) a placenta extract which is a cell activating agent.
【0005】[0005]
【発明の実施の形態】本発明の皮膚外用剤の(A)成分
であるアセロラ抽出物は、マルピギア属(Malpighia)
の果樹であるアセロラ(Acerola、学名 Malpighia emar
ginata DC;アセロラの学名は、時代、地域、及び研究
者により論文等への記載が異なっている。従来はMalpig
hia punicifolia L.及びMalpighia glabra L.がアセロ
ラの学名として混同されて使われているが、現在では、
1980年にSteven Nagyらによって編集された「TROPI
CAL AND SUBTROPICAL FRUITS」で記載されている Malpi
ghia emarginata DCが最も適当である。)の果実から抽
出溶媒を用いて抽出する。その抽出処理は、特に限定さ
れないが、適当な溶媒を用いて低温又は室温ないし加温
下で抽出される。BEST MODE FOR CARRYING OUT THE INVENTION The acerola extract, which is the component (A) of the external preparation for skin of the present invention, is a Malpighia genus.
The fruit tree of Acerola (scientific name Malpighia emar
ginata DC; The scientific name of acerola is differently written in papers and the like depending on the period, region, and researcher. Traditionally Malpig
hia punicifolia L. and Malpighia glabra L. are confused and used as the scientific name of acerola, but nowadays
Edited by Steven Nagy and others in 1980, "TROPI
Malpi described in "CAL AND SUBTROPICAL FRUITS"
ghia emarginata DC is the most suitable. Extraction is carried out from the fruit of 1) using an extraction solvent. The extraction treatment is not particularly limited, but extraction is performed at a low temperature or room temperature or under heating with a suitable solvent.
【0006】上記の抽出溶媒としては、例えば水;メチ
ルアルコール、エチルアルコール等の低級1価アルコー
ル;グリセリン、プロピレングリコール、1,3−ブチ
レングリコール等の液状多価アルコール等の1種または
2種以上を用いることができる。好ましい抽出方法の例
としては、精製水を用い、低温下にて抽出を行なった後
濾過し、更に20〜70%(W/W)の濃度になるよう
に1,3−ブチレングリコールを混合し、再び濾過を行
なう方法が挙げられる。Examples of the above-mentioned extraction solvent include water; lower monohydric alcohols such as methyl alcohol and ethyl alcohol; liquid polyhydric alcohols such as glycerin, propylene glycol, and 1,3-butylene glycol, and one or more species thereof. Can be used. As an example of a preferred extraction method, purified water is used for extraction at a low temperature, followed by filtration, and 1,3-butylene glycol is further mixed to a concentration of 20 to 70% (W / W). , And a method of performing filtration again.
【0007】本発明の皮膚外用剤におけるアセロラ抽出
物の配合量(含有量)は、乾燥固形分として好ましくは
0.00005〜5重量%(以下、「重量%」を単に
「%」で示す)であり、より好ましくは0.0005か
ら1%である。このアセロラ抽出物の含有量が0.00
005%より少ないと十分な効果が得られないことがあ
り、また、5%を超えて配合してもそれ以上の効果の増
大は見られない。The compounding amount (content) of the acerola extract in the external preparation for skin of the present invention is preferably 0.00005 to 5% by weight as dry solid content (hereinafter, "% by weight" is simply represented by "%"). And more preferably 0.0005 to 1%. The content of this acerola extract is 0.00
If it is less than 005%, a sufficient effect may not be obtained, and if it exceeds 5%, no further increase in effect is observed.
【0008】また、本発明の皮膚外用剤の(B)成分は
胎盤抽出物である。ブタ、ウシ等の胎盤抽出物が用いら
れる。一種又は二種以上を適宜選択して配合することが
できる。これは細胞賦活作用がある。本発明組成物にお
ける胎盤抽出物の配合量(含有量)は、好ましくは0.
00001〜10%、より好ましくは0.0001〜5
%である。抽出液のまま用いる場合は乾燥固形分として
換算する。胎盤抽出物の配合量がこの範囲内であれば、
アセロラ抽出物と組み合わせた場合、皮膚外用剤中のア
セロラ抽出物に影響を及ぼすことがなく、またアセロラ
抽出物が胎盤抽出物に作用して、皮膚外用剤は経時安定
性も良好で、優れた細胞賦活効果を発揮し、かつ優れた
使用感を有する。 The component (B) of the external preparation for skin of the present invention is
Placental extract. Placenta extracts from pigs, cows, etc.
Be done. One or two or more types may be appropriately selected and blended.
it can. This has a cell activating effect. In the composition of the present invention
The amount (content) of the placenta extract is preferably 0.
00001-10%, more preferably 0.0001-5
%. When using the extract as it is, it should be as dry solids.
Convert. If the amount of placenta extract is within this range,
When combined with acerola extract,
Acerola without affecting cerola extract
The extract acts on the placenta extract, and the skin external preparation is stable over time.
It has good activity, exerts an excellent cell activation effect, and is excellent
Have a feeling of use.
【0017】本発明の皮膚外用剤は、常法に従い必須成
分である(A)成分と(B)成分とを通常の皮膚外用剤
として知られる種々の形態の基剤に配合して調製するこ
とができる。皮膚外用剤の形態としては、特に限定され
ず、例えば、乳液、クリーム、化粧水、パック、洗浄料
等のスキンケア化粧料、口紅、ファンデーション等のメ
ーキャップ化粧料、頭皮用化粧料や、軟膏剤、分散液、
クリーム剤、外用液剤などの医薬品等とすることができ
その剤型についても特に制限はなく、固型状、ペースト
状、ムース状、ジェル状、粉末状、溶液系、可溶化系、
乳化系、粉末分散系、多層状とすることができる。The external preparation for skin of the present invention is prepared by blending the essential components (A) and (B) with various types of bases known as ordinary external preparations for skin according to a conventional method. You can The form of the external preparation for skin is not particularly limited, and examples thereof include emulsions, creams, lotions, packs, skin care cosmetics such as cleaning agents, lipsticks, makeup cosmetics such as foundations, scalp cosmetics, and ointments. Dispersion,
It can be used as a medicine such as a cream agent or a liquid agent for external use, and its dosage form is not particularly limited, and solid, paste, mousse, gel, powder, solution, solubilization,
It can be emulsified, powder dispersed, or multi-layered.
【0018】また、本発明の皮膚外用剤には、上記
(A)、(B)成分以外に、本発明の効果を損なわない
範囲で、通常、化粧料や医薬部外品、外用医薬品等の製
剤に使用される成分、すなわち、水、油剤、界面活性
剤、金属セッケン、ゲル化剤、粉体、アルコール類、水
溶性高分子、皮膜形成剤、樹脂、紫外線防御剤、包接化
合物、抗菌剤、香料、消臭剤、塩類、PH調整剤、清涼
剤、動物・微生物由来抽出物、植物抽出物、血行促進
剤、収斂剤、抗脂漏剤、活性酸素消去剤、美白剤、抗炎
症剤、角質溶解剤、酵素、ホルモン類、ビタミン類等を
適宜一種又は二種以上添加することができる。In addition to the above-mentioned components (A) and (B), the external preparation for skin of the present invention usually contains cosmetics, quasi-drugs, external medicines, etc. within a range not impairing the effects of the present invention. Ingredients used in the formulation, namely water, oils, surfactants, metal soaps, gelling agents, powders, alcohols, water-soluble polymers, film-forming agents, resins, UV protection agents, inclusion compounds, antibacterial agents Agents, fragrances, deodorants, salts, pH regulators, cooling agents, animal / microorganism-derived extracts, plant extracts, blood circulation promoters, astringents, antiseborrheic agents, active oxygen eliminators, whitening agents, anti-inflammatory One or more kinds of agents, keratolytic agents, enzymes, hormones, vitamins and the like can be added appropriately.
【0019】[0019]
【実施例】次に参考例、試験例及び実施例を挙げて本発
明を更に詳細に説明する。 EXAMPLES Next Reference Example, and Test Examples and Examples that explains the invention in more detail.
【0020】参考例1. アセロラ抽出物の製造
アセロラ(Acerola,学名 Malpighia emarginata DC)
の果実に精製水を加え、低温下にて1日間抽出を行なっ
た後濾過してアセロラ抽出物を得た(乾燥固形分1.7
%)。Reference Example 1. Production of acerola extract Acerola (scientific name: Malpighia emarginata DC)
Purified water was added to the fruit of the above, extraction was performed at low temperature for 1 day, and then filtration was performed to obtain an acerola extract (dry solid content 1.7).
%).
【0021】参考例2. 胎盤抽出物の製造
妊娠3〜4ヶ月の牛の胎盤1kgを凍結、融解後不純物
を洗浄、除去し、精製水5リットルを加え、減圧、低温
下で3日間抽出し、濾過して胎盤抽出物を得た(乾燥固
形分3.5%)。この抽出物は細胞賦活剤である。 Reference Example 2. Preparation of placenta extract 1 kg of placenta of a cow 3-4 months pregnant is frozen and thawed, impurities are washed and removed, 5 liters of purified water is added, extraction is performed under reduced pressure and low temperature for 3 days, and placenta extract is filtered. Was obtained (dry solid content 3.5%). This extract is a cell activator.
【0022】参考例3. オタネニンジン抽出物の製造
オタネニンジンの根250gを細切し、無水エタノール
1リットルを加えてブレンダーを用いて一昼夜撹拌抽出
し、ニンジン抽出物を得た(乾燥固形分1.1%)。こ
の抽出物は細胞賦活剤である。 Reference Example 3. Production of Panax ginseng root 250 g Panax ginseng root was shredded, 1 liter of absolute ethanol was added, and the mixture was stirred and extracted with a blender for one day to obtain a carrot extract (dry solid content 1.1%). This
The extract is a cell activator.
【0024】参考例4. 乳酸菌抽出物の製造
牛乳タンパク質水溶液1リットルに乳酸かん菌を1%接
種し、40℃で3日間培養する。得られた発酵乳を80
℃で瞬間殺菌し、濾過して乳酸菌抽出物を得た(乾燥固
形分9.5%)。この抽出物は細胞賦活剤である。 Reference Example 4 Preparation of Lactic Acid Bacteria Extract 1 liter of an aqueous milk protein solution is inoculated with 1% of Lactobacillus and cultured at 40 ° C. for 3 days. 80 fermented milk obtained
Instant sterilization at ℃, filtered to obtain a lactic acid bacterium extract (dry solid content 9.5%). This extract is a cell activator.
【0028】試験例1. 線維芽細胞増殖試験
シャーレに培地を適量取り、ヒト新生児線維芽細胞を播
種して、37℃で、二酸化炭素濃度5%中にて静置す
る。翌日、凍結乾燥した表1に示す各細胞賦活剤を濃度
が100μg/ml、アセロラ抽出物は100mg/m
lとなるようにPBS(リン酸緩衝液)に溶解し、培地
の1/10量をシャーレに添加混和する。対照として、
PBSを添加する。各試料に対する細胞数(A)及び対
照の細胞数(B)を測定し、次式により細胞増殖率を算
出した。その結果を表1に示す。
細胞増殖率(%)=(A/B)×100
但し、A:試料添加時の細胞数
B:試料無添加時の細胞数Test Example 1. Fibroblast proliferation test An appropriate amount of medium is placed in a petri dish, human neonatal fibroblasts are seeded, and the mixture is allowed to stand at 37 ° C in a carbon dioxide concentration of 5%. The next day, freeze-dried cell activating agents shown in Table 1 were used at a concentration of 100 μg / ml and the acerola extract was 100 mg / m 2.
It is dissolved in PBS (phosphate buffer solution) so that the amount becomes 1, and 1/10 amount of the medium is added to a petri dish and mixed. As a control
Add PBS. The cell number (A) and the control cell number (B) for each sample were measured, and the cell growth rate was calculated by the following formula. The results are shown in Table 1. Cell growth rate (%) = (A / B) × 100 where A: number of cells when sample is added B: number of cells when sample is not added
【0029】[0029]
【表1】 [Table 1]
【0030】表1の結果から明らかな如く、アセロラ抽
出物と細胞賦活剤たる胎盤抽出物及び/又はオタネニン
ジン抽出物とを組合わせることにより、非常に高い細胞
増殖促進効果が得られる。As is clear from the results in Table 1, by combining the acerola extract with the placenta extract and / or the ginseng extract which are cell activating agents, a very high cell growth promoting effect was obtained. To be
【0036】参考実施例1. 乳液の調製例
表2に示す組成の乳液を調製し、その皮膚老化防止効果
を調べた。その結果も併せて表2に示す。表中、AT
P、17β−エストラジオールは細胞賦活剤である。 Reference Example 1 Preparation Example of Emulsion An emulsion having the composition shown in Table 2 was prepared, and its skin aging prevention effect was examined. The results are also shown in Table 2 . AT in the table
P, 17β-estradiol is a cell activator.
【0037】[0037]
【表2】 [Table 2]
【0038】(製法)
A.成分(14)の一部と(6)、(11)及び(13)を加熱
混合し、70℃に保つ。
B.成分(1)〜(5)を加熱混合し、70℃に保つ。
C.上記Bを先のAに加えて混合し、成分(10)を加え
て均一に乳化し、30℃まで冷却して、成分(12)を加
え、均一に混合する。
D.成分(14)の残分に成分(7)〜(9)を混合し、Cに
加え、均一に混合し乳液を得る。(Production Method) A. A part of the component (14) and (6), (11) and (13) are mixed by heating and kept at 70 ° C. B. The components (1) to (5) are mixed by heating and kept at 70 ° C. C. The above B is added to the above A and mixed, and the component (10) is added to uniformly emulsify, and the mixture is cooled to 30 ° C. The component (12) is added and mixed uniformly. D. The components (7) to (9) are mixed with the rest of the component (14), added to C and uniformly mixed to obtain an emulsion.
【0039】(試験方法)
被験乳液1品につき26〜50才の女性15名をパネル
とし、毎日、朝と夜の2回、12週間にわたって洗顔後
に被験乳液の適量を顔面に塗布した。塗布による皮膚老
化防止効果を下の基準によって評価した。(Test Method) For each test emulsion, 15 women aged 26 to 50 were used as a panel. After washing the face twice daily in the morning and at night for 12 weeks, an appropriate amount of the test emulsion was applied to the face. The skin aging prevention effect by application was evaluated according to the following criteria.
【0040】皮膚老化防止効果:
〔評価〕 〔内 容〕
有 効 肌のはり、つやが改善された。
やや有効 肌のはり、つやがやや改善された。
無 効 使用前と変化なし。
上記評価方法により得られた結果を表3に併せて示す。
表2の結果から明らかな如く、本発明品に係わるアセロ
ラ抽出物と細胞賦活剤とを配合した乳液は、皮膚に適用
することにより、肌のはり、つやが改善され、皮膚の老
化を防止することができた。Skin Aging Preventive Effect: [Evaluation] [Contents] Effectiveness The skin's firmness and gloss were improved. Slightly effective Skin tone and gloss were slightly improved. Ineffective No change from before use. The results obtained by the above evaluation method are also shown in Table 3.
As is clear from the results of Table 2 , the emulsion containing the acerola extract and the cell activator according to the present invention, when applied to the skin, improves the skin's elasticity and gloss and prevents skin aging. I was able to.
【0041】参考
実施例2. 化粧水の調製例
(処方) (%)
(1)グリセリン 5.0
(2)1,3−ブチレングリコール 6.5
(3)ポリオキシエチレン(20E.O.)ソルビタン 1.2
モノラウリン酸エステル
(4)エチルアルコール 8.0
(5)アセロラ抽出物*1 1.0
(6)マルメロ抽出物*2 1.0
(7)オオムギ抽出物*3 1.0
(8)防腐剤 適量
(9)香料 適量
(10)アルカリ単純温泉水*4 50.0
(11)精製水 残量
*1 参考例1で製造したもの
*2 香栄興業社製
*3 テクノーブル社製:細胞賦活剤
*4 丸善製薬社製
(製法)
A.成分(3)、(4)、(8)及び(9)を混合溶解する。
B.成分(1)、(2)、(5)〜(7)、(10)及び(11)を
混合溶解する。
C.AとBを混合して均一にし、化粧水を得た。 Reference Example 2 Preparation Example (Prescription) of Cosmetic Lotion (%) (1) Glycerin 5.0 (2) 1,3-Butylene Glycol 6.5 (3) Polyoxyethylene (20 EO) Sorbitan 1.2 Monolauric acid ester (4) Ethyl alcohol 8.0 (5) Acerola extract * 1 1.0 (6) Quince extract * 2 1.0 (7) Barley extract * 3 1.0 (8 ) Preservative Suitable amount (9) Perfume Suitable amount (10) Alkaline simple hot spring water * 4 50.0 (11) Purified water Remaining amount * 1 Manufactured in Reference Example 1 * 2 Koei Kogyo Co., Ltd. * 3 Technoble Co., Ltd. : Cell activating agent * 4 manufactured by Maruzen Pharmaceutical Co., Ltd. (manufacturing method) A. Components (3), (4), (8) and (9) are mixed and dissolved. B. Components (1), (2), (5) to (7), (10) and (11) are mixed and dissolved. C. A and B were mixed and made uniform to obtain a lotion.
【0042】参考実施例2は、経時安定性に優れ、肌の
はり、つやを改善し、優れた保湿効果及び肌荒れ改善効
果を有する化粧水であった。 Reference Example 2 was a lotion which was excellent in stability over time, improved the firmness and gloss of the skin, and had an excellent moisturizing effect and rough skin improving effect.
【0049】参考 実施例3. 口紅の製造例 (処方) (%) (1)アセロラ抽出物*1 0.02 (2)γ−リノレン酸*2 0.02 (3)乳酸菌抽出物*3 0.001 (4)赤色202号 0.2 (5)キャンデリラロウ 9.0 (6)固形パラフィン 8.0 (7)ミツロウ 5.0 (8)カルナウバロウ 5.0 (9)ラノリン 11.0 (10)イソプロピルミリステート 10.0 (11)精製ヒマシ油 残量 (12)防腐剤 適量 (13)香料 適量 *1 参考例1で製造したもの *2 出光石油化学社製 *3 参考例4で製造したもの Reference Example 3 Production Example of Lipstick (Formulation) (%) (1) Acerola Extract * 1 0.02 (2) γ-Linolenic Acid * 2 0.02 (3) Lactic Acid Bacteria Extract * 30 0.001 (4) Red No. 202 0.2 (5) Candelilla wax 9.0 (6) Solid paraffin 8.0 (7) Beeswax 5.0 (8) Carnauba wax 5.0 (9) Lanolin 11.0 ( 10) Isopropyl myristate 10.0 (11) Refined castor oil Remaining amount (12) Preservative Suitable amount (13) Perfume Suitable amount * 1 Manufactured in Reference Example 1 * 2 Idemitsu Petrochemical * 3 Manufactured in Reference Example 4 What I did
【0050】(製法)
A.成分(5)〜(12)を加熱溶解後、3本ローラーで練
る。
B.Aに成分(1)〜(3)及び(13)を加えた後、再び3
本ローラーで練る。
C.Bを冷却・成型して口紅を得た。参考
実施例3は、口唇の荒れを防ぎ、良好な艶、はりを
もたらす口紅であった。(Production Method) A. After the components (5) to (12) are dissolved by heating, they are kneaded with three rollers. B. After adding components (1) to (3) and (13) to A, repeat 3 again.
Knead with a main roller. C. B was cooled and molded to obtain lipstick. Reference Example 3 was a lipstick which prevented roughening of the lips and gave good gloss and firmness.
【0051】[0051]
【発明の効果】本発明の皮膚外用剤はアセロラ抽出物と
細胞賦活剤の胎盤抽出物とを配合することにより、胎盤
抽出物の本来有する薬効の効能を十分に発揮させること
ができる。薬効成分として胎盤抽出物を併用した皮膚外
用剤は、安定で且つ優れた皮膚老化防止作用を有するた
め、皮膚のはりやつやを維持し、シワ形成に高い抑制効
果を発揮する。このように、本発明の皮膚外用剤は、ア
セロラ抽出物と共に配合することによって細胞賦活剤た
る胎盤抽出物の本来有する薬効を向上させることができ
るので、美容や医療において極めて有用なものである。The external preparation for skin of the present invention exhibits by blending and placenta extract acerola extract and cell activator, placenta
It is possible to fully exert the inherent efficacy of the extract . The external preparation for skin in which a placenta extract is used as a medicinal component is stable and has an excellent anti-aging effect on skin, and therefore maintains the skin's elasticity and gloss and exerts a high inhibitory effect on wrinkle formation . Thus, the external preparation for skin of the present invention was used as a cell activating agent by blending with the acerola extract .
Since it is possible to improve the inherent medicinal effect of the placenta extract, it is extremely useful in beauty and medicine.
───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.7 識別記号 FI A61K 35/78 A61K 35/78 C A61P 17/00 A61P 17/00 (72)発明者 上原 静香 東京都北区栄町48番18号 株式会社コー セー研究本部内 (72)発明者 佐々木 一郎 東京都北区栄町48番18号 株式会社コー セー研究本部内 (72)発明者 永峰 賢一 東京都東村山市美住町2−5−1−203 (72)発明者 木藤 孝 埼玉県川口市並木1−21−25−103 (56)参考文献 特開 平2−200610(JP,A) 特開 平10−109927(JP,A) 特開 平10−95704(JP,A) 特開 平7−277939(JP,A) 特開 平10−114670(JP,A) 特開 平9−291011(JP,A) 特開 平9−183718(JP,A) (58)調査した分野(Int.Cl.7,DB名) A61K 7/00 - 7/50 ─────────────────────────────────────────────────── ─── Continuation of front page (51) Int.Cl. 7 Identification code FI A61K 35/78 A61K 35/78 C A61P 17/00 A61P 17/00 (72) Inventor Shizuka Uehara 48-18 Sakaemachi, Kita-ku, Tokyo No. 48 Kose Research Headquarters (72) Inventor Ichiro Sasaki 48-18 Sakaemachi, Kita-ku, Tokyo Kose Research Headquarters (72) Inventor Kenichi Nagamine 2-5-1 Misumicho, Higashimurayama-shi, Tokyo -203 (72) Inventor Takashi Kido 1-21-25-103 Namiki, Kawaguchi City, Saitama Prefecture (56) Reference JP-A-2-200610 (JP, A) JP-A-10-109927 (JP, A) JP 10-95704 (JP, A) JP-A-7-277939 (JP, A) JP-A-10-114670 (JP, A) JP-A-9-291011 (JP, A) JP-A-9-183718 (JP , A) (58) Fields surveyed (Int.Cl. 7 , DB name) A61K 7/ 00- 7/50
Claims (2)
剤。1. A skin external preparation comprising the following components (A) and (B): (A) acerola extract (B) placenta extract .
て0.00005〜5重量%であり、胎盤抽出物の配合
量が0.00001〜10重量%である請求項1に記載
の皮膚外用剤。2. The external skin application according to claim 1, wherein the blended amount of the acerola extract is 0.00005 to 5% by weight as a dry solid content, and the blended amount of the placenta extract is 0.00001 to 10% by weight. Agent.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP01653699A JP3513873B2 (en) | 1999-01-26 | 1999-01-26 | External preparation for skin |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP01653699A JP3513873B2 (en) | 1999-01-26 | 1999-01-26 | External preparation for skin |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2000212027A JP2000212027A (en) | 2000-08-02 |
| JP3513873B2 true JP3513873B2 (en) | 2004-03-31 |
Family
ID=11918999
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP01653699A Expired - Fee Related JP3513873B2 (en) | 1999-01-26 | 1999-01-26 | External preparation for skin |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP3513873B2 (en) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3504589B2 (en) | 2000-06-28 | 2004-03-08 | 株式会社ノエビア | External preparation for skin |
| JP2002138028A (en) * | 2000-10-30 | 2002-05-14 | Pias Arise Kk | External preparation for skin and method for producing the same |
| JP2002302401A (en) * | 2001-04-02 | 2002-10-18 | Okinawa Prefecture Deep Ocean Water Development Coop Society | Freshness liquid and method for producing the same |
| TWI332401B (en) * | 2001-08-21 | 2010-11-01 | Shiseido Co Ltd | Materials which are capable of enhancing laminin-5 producing ability in epidermal cell and the use thereof |
| JP3847649B2 (en) * | 2002-04-01 | 2006-11-22 | 株式会社ノエビア | Topical skin preparation |
| US20060165644A1 (en) * | 2002-08-14 | 2006-07-27 | Fancl Corporation | Cosmetics |
| JP4088829B2 (en) | 2002-11-25 | 2008-05-21 | 株式会社ニチレイバイオサイエンス | Antioxidants, cosmetics and food |
| JP4787461B2 (en) * | 2003-05-15 | 2011-10-05 | 花王株式会社 | Skin cosmetics |
| WO2005105126A1 (en) * | 2004-04-30 | 2005-11-10 | National University Corporation NARA Institute of Science and Technology | Active oxygen eliminator and moisturizer containing wild watermelon extract |
| JP4532257B2 (en) * | 2004-12-22 | 2010-08-25 | 株式会社ニチレイバイオサイエンス | A novel polyphenol glycoside derived from acerola |
| JP4975412B2 (en) * | 2006-11-02 | 2012-07-11 | ホーユー株式会社 | Moisturizer for skin and external preparation for skin |
| JP2009040757A (en) * | 2007-08-10 | 2009-02-26 | Maruzen Pharmaceut Co Ltd | Agent promoting laminin 5 production, agent normalizing dermal basement membrane, and agent promoting recovery of skin lesion |
| JP2009046425A (en) * | 2007-08-20 | 2009-03-05 | Noevir Co Ltd | Skin care preparation for external use and humectant |
| JP2009073777A (en) * | 2007-09-21 | 2009-04-09 | Kao Corp | Cosmetics |
| IT1393547B1 (en) * | 2009-04-01 | 2012-04-27 | Salati | COSMETIC COMPOSITION WITH MOISTURIZING ACTIVITY AND FAVORABLE SKIN ELECTICITY |
| JP2011207769A (en) * | 2010-03-29 | 2011-10-20 | Arubion:Kk | Cosmetic and skin care preparation for external use |
| JP2012056933A (en) * | 2010-09-13 | 2012-03-22 | Maruzen Pharmaceut Co Ltd | Elastin production promoter |
| JP6009147B2 (en) * | 2011-03-15 | 2016-10-19 | 株式会社 資生堂 | Bleomycin hydrolase production promoter |
| CN103340811B (en) * | 2011-09-27 | 2015-03-25 | 浙江欧诗漫生物股份有限公司 | Lotion composition containing sambucus canadensis extracts, pansy extracts and hydrolyzed pearls |
| CN103222943B (en) * | 2011-09-27 | 2015-03-25 | 沈志荣 | Preparation method for instantaneous penetration skin regeneration water composition containing pansy flower extract, guava extract and hydrolyzed pearl |
| CN103222946B (en) * | 2011-09-27 | 2015-04-15 | 沈志荣 | Preparation method for instantaneous penetration skin regeneration water composition containing American elderberry extract, guava extract and hydrolyzed pearl |
| CN103230352B (en) * | 2011-09-27 | 2014-08-20 | 沈志荣 | Method for preparing plant extract and hydrolyzed pearl-containing toner composition |
| CN103340810B (en) * | 2011-09-27 | 2015-03-25 | 浙江欧诗漫生物股份有限公司 | Lotion composition containing coconut/seaweed composite extracts, ginseng root extracts and hydrolyzed pearls |
| CN103239371B (en) * | 2011-09-27 | 2014-07-30 | 沈志荣 | Preparation method of toning lotion composition containing chamomile extract and panax ginseng extract |
| CN104940047B (en) * | 2015-06-25 | 2017-12-01 | 广州保税区雅兰国际化妆品有限公司 | A kind of cosmetic composition of replenishing water and preserving moisture and preparation method thereof |
| CN105213256A (en) * | 2015-10-08 | 2016-01-06 | 青岛海之源智能技术有限公司 | A kind of Shu Min dispels red toner/smoothing toner and preparation method thereof |
| CN105853327A (en) * | 2016-04-11 | 2016-08-17 | 吴金霞 | Traditional Chinese medicine cosmetic capable of tendering skin and maintaining youth |
| JP2018052904A (en) * | 2016-09-30 | 2018-04-05 | 小林製薬株式会社 | External composition |
| KR102022068B1 (en) * | 2017-12-20 | 2019-09-18 | 청담씨디씨제이앤팜 유한책임회사 | Method for production of Malpighia emarginata fruit extract without mass destruction of effective compound and cosmetic composition with the extract |
| CN112870126A (en) * | 2021-03-06 | 2021-06-01 | 广州中草世家化妆品有限公司 | Efficient moisturizing composition rich in ginseng essence and preparation method and application thereof |
| CN115590772A (en) * | 2022-10-31 | 2023-01-13 | 北京茂思商贸有限公司(Cn) | Double-layer essential oil with anti-wrinkle repairing effect and preparation method thereof |
-
1999
- 1999-01-26 JP JP01653699A patent/JP3513873B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JP2000212027A (en) | 2000-08-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP3513873B2 (en) | External preparation for skin | |
| US5965145A (en) | Use of honey as keratolytic agent for improving the radiance and the complexion of the skin and treating wrinkles | |
| JPH1053510A (en) | Composition for external use | |
| JP4252460B2 (en) | Skin preparation for external use | |
| JPH10182412A (en) | External-use medical preparation | |
| JPH0469123B2 (en) | ||
| JP7135106B2 (en) | Scalp and hair composition | |
| JP3513872B2 (en) | External preparation for skin | |
| JPH09183718A (en) | Composition suitable for external application | |
| JPH0840824A (en) | Cosmetic | |
| JPH0465045B2 (en) | ||
| JP3507635B2 (en) | Composition suitable for external use | |
| JP3505003B2 (en) | External preparation | |
| KR101322850B1 (en) | The cosmetic composition for pore-minimizing and inhibition of Sebum Secretion containing the extract of leaves of Mentha arvensis var. piperascens, wheat bud, and Platycodon grandiflorum | |
| JPH069363A (en) | Medicinal cosmetic | |
| JP3133532B2 (en) | Hair restoration cosmetics | |
| JP3083105B2 (en) | Cosmetics | |
| JPH11302147A (en) | Cosmetic | |
| JPH0820522A (en) | Keratinizing anzyme activity promoter and cosmetic containing the same | |
| US20030152599A1 (en) | Composition for external use | |
| JPH11302133A (en) | Cosmetic for scalp and hair | |
| JPH11279023A (en) | Composition for external use | |
| JP2780805B2 (en) | New skin external preparation composition | |
| JPH10273424A (en) | Cosmetic for hair | |
| JP2000327553A (en) | External preparation for skin |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| TRDD | Decision of grant or rejection written | ||
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20040105 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 3513873 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313115 |
|
| R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130123 Year of fee payment: 9 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130123 Year of fee payment: 9 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20160123 Year of fee payment: 12 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| LAPS | Cancellation because of no payment of annual fees |